INTRODUCTION
Multiple sclerosis (MS) is a progressive neurodegenerative disease affecting the central nervous system. Positron emission tomography (PET) and computed tomography (CT) are effective techniques to measure the metabolic activity of tissues at rest and after exercise. Using these techniques glucose uptake in tissues can be measured with the PET glucose analog, [ 
CASE REPORT
Eight mildly disabled, but ambulatory, patients with relapsing remitting form of MS and eight healthy age-/sex-matched participants performed 15 min of treadmill walking at a self-selected comfortable speed. Two minutes after walking began, each participant was injected with E8 mCi of [ 18 F]-FDG. PET/CT imaging was performed and image analysis was conducted using Analyze 11.0 (Mayo Clinic, Rochester, NY, USA). Standardized uptake values (SUV mean ) were calculated at mid-vertebral body level, C 1 -L 1 . 2 Spinal cord regions were defined as: whole C 1 -L 1 , cervical C 1 -C 7 , thoracic T 1 -T 10 , lumbar T 11 -T 12 , sacral L 1 , to account for the mismatch between vertebral body and spinal cord segments. 3 Patients with MS walked at a slower self-selected speed than the healthy participants and [ 18 F]-FDG uptake was lower throughout the whole spinal cord (1.48±0.36 and 1.55±0.33, P ¼ 0.04) and specifically within the thoracic (1.32 ± 0.27 and 1.41 ± 0.24, Po0.01) and lumbar (1.58 ± 0.40 and 1.89 ± 0.43, P ¼ 0.04) regions. P-values were based on independent t-tests and Mann-Whiney U-test according to KolmogorovSmirnov tests of normality (Table 1) (Figures 1 and 2 ). Disability levels were determined by patient-determined disease step scores (1.9±1.6) that correspond to Expanded Disability Status Scale 4 (3.0 ± 1.7). Images were analyzed retrospectively from a previous investigation looking at differences in [ 18 F]-FDG uptake in patients with MS after walking.
preceded by CT scans for attenuation correction and for anatomical reference. Consecutive scans were performed to maintain co-registration. The data sets were reconstructed using an iterative method (ordered subset expectation maximization) with 33 subsets and 3 iterations with a Gaussian filter.
DISCUSSION
The spinal cord is the link between the brain and peripheral effector organs and muscles; however, it can be overlooked in disease diagnosis/progression and rehabilitative strategies in patients with MS. Our main finding was lower [ 18 F]-FDG uptake within the whole spinal cord and specifically within thoracic and lumbar spinal cord segments. Sympathetic branches of the autonomic nervous system (ANS) and motor neuron pools of the lower limbs are located within these regions. ANS dysfunction is one of the most common side effects in MS. Furthermore, failure to activate central pattern generators and lower motor neuron pools during walking could be contributing to the impaired walking ability of patients with MS. Figure 1 displays high activity of the lumbar spinal cord within the healthy controls but is absent in patients with MS. Alterations in glucose metabolism/uptake might be a contributing factor to ANS side effects and alterations in walking ability, but there is no published literature regarding this.
Cheng et al. 5 demonstrated the use of [ 18 F]-FDG in the diagnosis of spinal cord neuropathies. Their investigation showed the usefulness of this technique in investigating nervous system dysfunctions and functional outcomes. Appling these methods in the study of MS could provide useful data in determining changes in disability associated with ANS and peripheral effectors, allowing for new estimates/ predictions of disability in this population. Further studies are needed to determine whether the lower [ 18 F]-FDG uptake in the spinal cord during walking is due to the reduced walking speed of patients with MS or whether it is pathological to their disease. Studies at rest and during exercise are also needed to correlate these results with disability levels, motor performance, age, sex, duration and disease type.
CONCLUSION
These data provide the justification to continue work on investigating the metabolic activity of the spinal cord, at rest and during exercise, and how it affects measures of disability in diseased populations, especially MS. With an extended knowledge on this subject, it is possible that new drug and rehabilitative strategies may improve the condition of common side effects in MS. 
